APGE - Apogee Therapeutics, Inc.
73.05
2.130 2.916%
Share volume: 607,065
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$70.92
2.13
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-13-2024 | 08-12-2024 | 11-12-2024 | 03-03-2025 | 05-12-2025 | 11-10-2025 | 03-02-2026 | |
| Assets | ||||||||
| Total Assets | 823.659 M | 800.657 M | 776.286 M | 753.951 M | 714.162 M | 626.159 M | 937.134 M | |
| Current Assets | 820.608 M | 681.853 M | 534.483 M | 529.713 M | 521.531 M | 540.097 M | 741.358 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 330.739 M | 368.929 M | 407.269 M | 378.864 M | 406.413 M | 419.375 M | 598.643 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 485.457 M | 307.299 M | 118.780 M | 141.789 M | 106.916 M | 107.914 M | 131.549 M | |
| Total Non-current Assets | 0.000 | 113.395 M | 227.746 M | 210.416 M | 168.106 M | 61.640 M | 172.730 M | |
| Property Plant Equipment | 699.000 K | 714.000 K | 1.417 M | 1.959 M | 5.679 M | 6.032 M | 5.688 M | |
| Other Assets | 2.352 M | 118.090 M | 240.386 M | 222.279 M | 186.952 M | 80.030 M | 190.088 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 823.659 M | 800.657 M | 776.286 M | 753.951 M | 714.162 M | 626.159 M | 937.134 M | |
| Total liabilities | 22.181 M | 27.018 M | 41.884 M | 37.157 M | 40.800 M | 39.821 M | 33.251 M | |
| Total current liabilities | 21.551 M | 24.617 M | 32.611 M | 28.560 M | 32.960 M | 34.047 M | 27.906 M | |
| Accounts Payable | 4.302 M | 5.527 M | 2.216 M | 1.071 M | 2.445 M | 376.000 K | 1.221 M | |
| Other liabilities | 630.000 K | 2.401 M | 9.273 M | 8.597 M | 7.840 M | 5.774 M | 5.345 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 630.000 K | 2.401 M | 9.273 M | 8.597 M | 7.840 M | 5.774 M | 5.345 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 801.478 M | 773.639 M | 734.402 M | 716.794 M | 673.362 M | 586.338 M | 903.883 M | |
| Common stock | 957.519 M | 963.608 M | 969.830 M | 1.022 B | 1.034 B | 1.078 B | 1.465 B | |
| Retained earnings | -155.864 M | -189.680 M | -238.698 M | -305.916 M | -361.255 M | -492.372 M | -561.759 M |